Eur Rev Med Pharmacol Sci 2024; 28 (9): 3455-3462
DOI: 10.26355/eurrev_202405_36191

Retrospective evaluation of gestational trophoblastic disease – experience with ultrasounds

O. Gunenc, M. Geyik Bayman, E. Omeroglu, N.G. Kulhan, M.C. Ates, A.N. Uğur Kilinc, E.N. Yildirim Ozturk

Obstetric and Gynecology Department, Sağlık Bilimleri University, Konya City Hospital, Konya, Turkey. gozdemirel1@hotmail.com


OBJECTIVE: Our study aims to determine the frequency and types of GTD (Gestational Trophoblastic Disease) in our clinic, to evaluate its relationship with clinical parameters, and the consistency of clinical prediagnosis and pathological definitive diagnosis.

PATIENTS AND METHODS: In the present study, hospital records of 120 patients with gestational trophoblastic disease between January 2019 and August 2022 were obtained and evaluated retrospectively. Demographic, hematological, biochemical, and clinical data were collected in detail, and the data were analyzed statistically.

RESULTS: Our study included a total of 120 female patients, with an average age of 31.16±9.70. The average number of patients was 3. The average time for women to receive the diagnosis was 9.80±2.45 weeks, with the most frequent complaint on our part being bleeding (85.8%). When the pathology outcomes of the patients we included in our study were examined, it was found that the number of patients diagnosed with incomplete abortion was 34, the number of patients diagnosed with complete abortion was 82, the number of invasive moles diagnosed was 3, and the number of patient diagnosed with choriocarcinoma was 1. Kappa ratio was calculated as 0.419 (p<0.001) when the compliance of the clinical diagnosis was assessed. This value was consistent with median level alignment. In a study that examined the three years of our calism in our bulk, 1.8 per 1,000 births were followed frequently.

CONCLUSIONS: We should inform patients in detail about gestational trophoblastic diseases and warn patients not to delay their consequences. We should recommend that pregnancy be avoided for 12 months for low-risk patients and 18 months for high-risk patients after GTD.

Free PDF Download

To cite this article

O. Gunenc, M. Geyik Bayman, E. Omeroglu, N.G. Kulhan, M.C. Ates, A.N. Uğur Kilinc, E.N. Yildirim Ozturk
Retrospective evaluation of gestational trophoblastic disease – experience with ultrasounds

Eur Rev Med Pharmacol Sci
Year: 2024
Vol. 28 - N. 9
Pages: 3455-3462
DOI: 10.26355/eurrev_202405_36191